Liang‐yun Li

548 total citations
29 papers, 418 citations indexed

About

Liang‐yun Li is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Liang‐yun Li has authored 29 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Liang‐yun Li's work include Liver Disease Diagnosis and Treatment (10 papers), Liver physiology and pathology (7 papers) and Circular RNAs in diseases (6 papers). Liang‐yun Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver physiology and pathology (7 papers) and Circular RNAs in diseases (6 papers). Liang‐yun Li collaborates with scholars based in China, Saint Kitts and Nevis and Thailand. Liang‐yun Li's co-authors include Tao Xu, Hong Zhou, Junfa Yang, Jun Li, Jun Li, Yan Qi, Li Li, Xiao‐Ming Meng, Chenchen Yang and Shuang Hu and has published in prestigious journals such as Gene, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Liang‐yun Li

29 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang‐yun Li China 14 213 107 99 76 49 29 418
Yangqiu Bai China 12 181 0.8× 80 0.7× 96 1.0× 75 1.0× 38 0.8× 26 418
Junfa Yang China 17 292 1.4× 123 1.1× 204 2.1× 70 0.9× 58 1.2× 35 546
Cunzao Wu China 11 253 1.2× 96 0.9× 115 1.2× 82 1.1× 27 0.6× 19 474
Bénédicte Delire Belgium 8 178 0.8× 149 1.4× 82 0.8× 148 1.9× 53 1.1× 19 443
Siwei Xia China 14 222 1.0× 184 1.7× 96 1.0× 92 1.2× 31 0.6× 30 537
Zhining Liu China 11 164 0.8× 59 0.6× 89 0.9× 37 0.5× 34 0.7× 28 386
Yang Cheng China 14 331 1.6× 144 1.3× 206 2.1× 59 0.8× 44 0.9× 36 606
Ming–Heng Wu Taiwan 8 201 0.9× 51 0.5× 108 1.1× 55 0.7× 36 0.7× 9 435
Baolin Qian China 10 124 0.6× 62 0.6× 39 0.4× 58 0.8× 33 0.7× 34 290

Countries citing papers authored by Liang‐yun Li

Since Specialization
Citations

This map shows the geographic impact of Liang‐yun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐yun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐yun Li more than expected).

Fields of papers citing papers by Liang‐yun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐yun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐yun Li. The network helps show where Liang‐yun Li may publish in the future.

Co-authorship network of co-authors of Liang‐yun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐yun Li. A scholar is included among the top collaborators of Liang‐yun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐yun Li. Liang‐yun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Liang‐yun, et al.. (2025). Synthesis of 20α/β-hydroxyprogesterone-trimethyl lock-triglyceride-mimetic prodrugs and its bioavailability study in rats. Bioorganic & Medicinal Chemistry. 128. 118285–118285. 1 indexed citations
2.
Li, Liang‐yun, et al.. (2024). Study on 20-hydroxyprogesterone: Chiral resolution, content determination and progesterone-like activity. The Journal of Steroid Biochemistry and Molecular Biology. 244. 106592–106592. 2 indexed citations
3.
Zhu, Sai, Xin Chen, Xiaofeng Li, et al.. (2024). N6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis. Acta Pharmaceutica Sinica B. 15(1). 296–313. 4 indexed citations
4.
Zhao, Yuxin, Ying-Yin Sun, Liang‐yun Li, et al.. (2024). Rab11b promotes M1-like macrophage polarization by restraining autophagic degradation of NLRP3 in alcohol-associated liver disease. Acta Pharmacologica Sinica. 46(1). 134–146. 4 indexed citations
5.
Li, Liang‐yun, et al.. (2023). Lipid-based formulations: A promising approach for poorly soluble drug delivery via the intestinal lymphatic system. Journal of Drug Delivery Science and Technology. 87. 104770–104770. 18 indexed citations
6.
Li, Liang‐yun, Zixiang Chen, Jintong Zhang, et al.. (2023). DNMT3a-mediated methylation of TCF21/hnRNPA1 aggravates hepatic fibrosis by regulating the NF-κB signaling pathway. Pharmacological Research. 193. 106808–106808. 7 indexed citations
7.
Li, Liang‐yun, Yihui Bi, Xiaofeng Li, et al.. (2022). Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice. Biochemical Pharmacology. 200. 115032–115032. 10 indexed citations
8.
Hu, Shuang, Xingyu Zhu, Shaowei Jiang, et al.. (2021). The Role of IL-35 in the Pathophysiological Processes of Liver Disease. Frontiers in Pharmacology. 11. 569575–569575. 8 indexed citations
9.
Li, Peng, Shuang Hu, Qian Cheng, et al.. (2021). The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19. Frontiers in Pharmacology. 12. 650425–650425. 7 indexed citations
10.
Li, Liang‐yun, Junfa Yang, Shuang Hu, et al.. (2021). ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway. Acta Pharmacologica Sinica. 42(10). 1676–1689. 28 indexed citations
11.
Zhou, Hong, Jie Min, Shuang Hu, et al.. (2021). Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering. International Journal of Biological Sciences. 17(2). 651–669. 10 indexed citations
12.
Hu, Shuang, Yan Yao, Shuxian Wang, et al.. (2021). Deletion of p38γ attenuates ethanol consumption- and acetaminophen-induced liver injury in mice through promoting Dlg1. Acta Pharmacologica Sinica. 43(7). 1733–1748. 10 indexed citations
13.
Xu, Tao, Liang‐yun Li, Shuang Hu, et al.. (2020). MicroRNA‐708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. Journal of Cellular and Molecular Medicine. 24(13). 7127–7140. 16 indexed citations
14.
Yang, Junfa, Qing Tao, Yiwen Zhou, et al.. (2020). MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt/β-catenin pathway. European Journal of Pharmacology. 871. 172927–172927. 20 indexed citations
15.
Hu, Shuang, Yumin Liu, Liang‐yun Li, et al.. (2020). MicroRNA-708 prevents ethanol-induced hepatic lipid accumulation and inflammatory reaction via direct targeting ZEB1. Life Sciences. 258. 118147–118147. 15 indexed citations
16.
Xu, Tao, Li Li, Yuchen Liu, et al.. (2020). CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity. International Journal of Biological Sciences. 16(13). 2283–2295. 14 indexed citations
17.
Hu, Shuang, Suwen Li, Qi Yan, et al.. (2019). Natural products, extracts and formulations comprehensive therapy for the improvement of motor function in alcoholic liver disease. Pharmacological Research. 150. 104501–104501. 26 indexed citations
18.
Li, Liang‐yun, Hong Zhou, Yumin Liu, et al.. (2019). TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research. Toxicology Letters. 317. 82–91. 12 indexed citations
19.
Li, Liang‐yun, Hong Zhou, Junfa Yang, et al.. (2019). Relevance function of microRNA-708 in the pathogenesis of cancer. Cellular Signalling. 63. 109390–109390. 24 indexed citations
20.
Dong, Donglin, Wenjie Sun, Wei Zhang, et al.. (2011). Study on infiltration of Tianjin river systems in different typical years based on mapinfo. 6888–6891. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangqiu Bai Breakdown of academic impact, for papers by Junfa Yang Breakdown of academic impact, for papers by Cunzao Wu Breakdown of academic impact, for papers by Bénédicte Delire Breakdown of academic impact, for papers by Siwei Xia Breakdown of academic impact, for papers by Zhining Liu Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Ming–Heng Wu Breakdown of academic impact, for papers by Baolin Qian
Rankless by CCL
2026